Chimera Bioengineering
Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.
Launch date
Employees
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
| N/A | N/A | Seed | |
N/A | Series A | ||
| N/A | $16.3m | Late VC | |
N/A | Convertible | ||
* | N/A | $7.5m | Grant |
| Total Funding | $23.8m | ||
